Pancuronium and Omeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pancuronium (pancuronium bromide) and Omeprazole (omeprazole). Common drug interactions include pulmonary embolism among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Pancuronium and Omeprazole. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Pancuronium?

Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,610 Omeprazole users. Check the latest studies of Omeprazole.



On Jan, 10, 2026

36 people who take Pancuronium and Omeprazole together, and have interactions are studied.

Pancuronium and Omeprazole drug interactions.

What are the common drug interactions of Pancuronium and Omeprazole, by gender? *:

female:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Pupillary reflex impaired
  3. Abdominal pain
  4. Acidosis (build-up of carbon dioxide in the blood)
  5. Activated partial thromboplastin time prolonged
  6. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  7. Anaemia (lack of blood)
  8. Anaesthetic complication
  9. Anaesthetic complication neurological
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Hypertension (high blood pressure)
  3. Cholangitis (infection of the bile duct)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Critical illness polyneuropathy
  6. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  7. Endocarditis (inflammation in heart muscle)
  8. Gastritis (inflammation of stomach)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Pancuronium and Omeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Acute respiratory distress syndrome
  3. Blood pressure decreased
  4. Oedema (fluid collection in tissue)
  5. Pyelonephritis (inflammation of kidney caused by bacteria)
  6. Pyrexia (fever)
  7. Weight increased
  8. Drug toxicity
  9. Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
  10. Enterococcal infection

50-59:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Anaemia (lack of blood)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood creatine phosphokinase mb increased
  6. Blood creatinine increased
  7. Blood lactate dehydrogenase increased
  8. Blood magnesium decreased
  9. Bradycardia (abnormally slow heart action)
  10. C-reactive protein increased

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Hypertension (high blood pressure)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Critical illness polyneuropathy
  5. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  6. Endocarditis (inflammation in heart muscle)
  7. Gastritis (inflammation of stomach)
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Oesophageal candidiasis (fungal infection of oesophagus)

What are the existing conditions these people have? *

  1. Anaesthesia: 4 people, 11.11%
  2. Constipation: 4 people, 11.11%
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 5.56%
  4. Cardiogenic Shock (inadequate circulation of blood): 2 people, 5.56%
  5. Confusional State: 2 people, 5.56%
  6. Depression: 2 people, 5.56%
  7. High Blood Cholesterol: 2 people, 5.56%
  8. High Blood Pressure: 2 people, 5.56%
  9. Stupor (lack of critical cognitive function and level of consciousness): 2 people, 5.56%
  10. Stable Angina (a constant chest pain): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pancuronium and Omeprazole?

- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pancuronium and Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pancuronium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pancuronium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pancuronium bromide and omeprazole (the active ingredients of Pancuronium and Omeprazole, respectively), and Pancuronium and Omeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: